These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31357140)

  • 1. Assessment of antiviral therapeutics in animal models of Lassa fever.
    Warner BM; Siragam V; Stein DR
    Curr Opin Virol; 2019 Aug; 37():84-90. PubMed ID: 31357140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
    Safronetz D; Rosenke K; Westover JB; Martellaro C; Okumura A; Furuta Y; Geisbert J; Saturday G; Komeno T; Geisbert TW; Feldmann H; Gowen BB
    Sci Rep; 2015 Oct; 5():14775. PubMed ID: 26456301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
    Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
    Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates.
    Stein DR; Warner BM; Audet J; Soule G; Siragam V; Sroga P; Griffin BD; Leung A; Grolla A; Tierney K; Albietz A; Kobasa D; Musa AS; Ahmad A; Akinpelu AM; Mba N; Rosenke R; Scott DP; Saturday G; Ihekweazu C; Safronetz D
    PLoS Pathog; 2021 Oct; 17(10):e1009966. PubMed ID: 34634087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation.
    Maruyama J; Manning JT; Mateer EJ; Sattler R; Bukreyeva N; Huang C; Paessler S
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31554720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lassa antiviral LHF-535 protects guinea pigs from lethal challenge.
    Cashman KA; Wilkinson ER; Posakony J; Madu IG; Tarcha EJ; Lustig KH; Korth MJ; Bedard KM; Amberg SM
    Sci Rep; 2022 Nov; 12(1):19911. PubMed ID: 36402782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lassa fever-induced sensorineural hearing loss: A neglected public health and social burden.
    Mateer EJ; Huang C; Shehu NY; Paessler S
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006187. PubMed ID: 29470486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine platforms to control Lassa fever.
    Lukashevich IS; Pushko P
    Expert Rev Vaccines; 2016 Sep; 15(9):1135-50. PubMed ID: 27136941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The search for animal models for Lassa fever vaccine development.
    Lukashevich IS
    Expert Rev Vaccines; 2013 Jan; 12(1):71-86. PubMed ID: 23256740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives.
    Aloke C; Obasi NA; Aja PM; Emelike CU; Egwu CO; Jeje O; Edeogu CO; Onisuru OO; Orji OU; Achilonu I
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current small animal models for LASV hearing loss.
    Sattler RA; Maruyama J; Shehu NY; Makishima T; Paessler S
    Curr Opin Virol; 2019 Aug; 37():118-122. PubMed ID: 31479989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever.
    Abreu-Mota T; Hagen KR; Cooper K; Jahrling PB; Tan G; Wirblich C; Johnson RF; Schnell MJ
    Nat Commun; 2018 Oct; 9(1):4223. PubMed ID: 30310067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lassa virus diversity and feasibility for universal prophylactic vaccine.
    Lukashevich IS; Paessler S; de la Torre JC
    F1000Res; 2019; 8():. PubMed ID: 30774934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the cryptic nature of Lassa fever in West Africa.
    Gibb R; Moses LM; Redding DW; Jones KE
    Pathog Glob Health; 2017 Sep; 111(6):276-288. PubMed ID: 28875769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Lassa antiviral compound ST-193 in a guinea pig model.
    Cashman KA; Smith MA; Twenhafel NA; Larson RA; Jones KF; Allen RD; Dai D; Chinsangaram J; Bolken TC; Hruby DE; Amberg SM; Hensley LE; Guttieri MC
    Antiviral Res; 2011 Apr; 90(1):70-9. PubMed ID: 21371508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments.
    Murphy HL; Ly H
    Virulence; 2021 Dec; 12(1):2989-3014. PubMed ID: 34747339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary and emerging pharmacotherapeutic agents for the treatment of Lassa viral haemorrhagic fever disease.
    Joseph AA; Fasipe OJ; Joseph OA; Olatunji OA
    J Antimicrob Chemother; 2022 May; 77(6):1525-1531. PubMed ID: 35296886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.
    Salu OB; Amoo OS; Shaibu JO; Abejegah C; Ayodeji O; Musa AZ; Idigbe I; Ezechi OC; Audu RA; Salako BL; Omilabu SA
    Pan Afr Med J; 2020; 36():253. PubMed ID: 33014249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.